Evonik VESTAMID® Care ML19 is a medical-grade polyamide 12 (PA12) resin supplied as natural, unpigmented cylindrical pellets. The ML19 grade identifier denotes a medium-viscosity extrusion material within the VESTAMID® Care portfolio, produced by hydrolytic polycondensation of laurolactam. In the manufacturer’s published technical data, the material exhibits a density of 1.01 g/cm³ per ISO 1183, a melting temperature of 176 °C per ISO 11357-3, and a viscosity number of 190 cm³/g per ISO 307. Moisture absorption at saturation is 1.2% per ISO 62, which is low relative to PA6 and PA66 and reduces dimensional variability associated with humidity cycling in medical tubing.

Tensile property data for conditioned specimens show a tensile modulus of 400 MPa per ISO 527-2 and a tensile stress at yield of 32 MPa per ISO 527-2. Nominal strain at break exceeds 200% per ISO 527-2, and Charpy notched impact strength at 23 °C is 7 kJ/m² per ISO 179/1eA. Hardness is 55 Shore D per ISO 868. The combination of moderate yield stress and high elongation is relevant for catheter shafts that must resist buckling during insertion while accommodating flexure without kinking.

Documented applications include extruded catheter shafts, multi-lumen tubing, and fluid-delivery lines in short-term and long-term body-contact devices. The viscosity supports thin-wall processing in optimized tooling, but minimum wall thickness remains dependent on die geometry, draw-down ratio, and lumen configuration. The following table reports typical values from the manufacturer’s technical datasheet. These are single-point values, not engineering design limits; finished device performance must be evaluated on the final geometry after sterilization and conditioning.

What Separates ML19 from Generic Polyamide 12 and Polyether Block Amide Elastomers?

Relative to VESTAMID® Care ML21, ML19 has a lower melt viscosity, expressed as a viscosity number of 190 cm³/g per ISO 307. ML21 is a higher-melt-strength grade used where blow molding, large thin-walled lumens, or co-extrusion with high-viscosity tie layers demands greater sag resistance. In single-lumen catheter extrusion, ML19 typically permits lower head pressure at equivalent screw speed and barrel setting. This is useful in multi-lumen tools where melt distribution must remain balanced across narrow flow channels. The lower viscosity also reduces viscous heat generation, but it narrows the acceptable residence-time window at the upper end of the melt-temperature range.

Compared with generic PA12, VESTAMID® Care ML19 carries formulation lock and a biocompatibility documentation package. Generic PA12 may differ in catalyst residues, monomer content, or additive loading, and those variables can alter extraction profiles in finished devices. In VESTAMID® Care ML19, the manufacturer controls polymerization and pelletization under a medical change-management system, and the grade is plasticizer-free. Flexibility is obtained from the inherent chain dynamics of PA12 rather than from added ortho-phthalate or citrate plasticizers, so plasticizer migration is not a primary extractables source.

Compared with polyether block amide elastomers used in balloon catheters, ML19 has less elastomeric recovery at strains above 100%. Some PEBA grades can achieve lower Shore D hardness and greater elastic return, but they may differ in chemical resistance and moisture transmission. Compared with TPU, the PA12 backbone of ML19 shows lower surface tack and higher dimensional stability under humid storage, but TPU can provide lower hardness without external plasticizers. Selection among these materials requires device-specific comparison of flexural modulus, burst-pressure retention, and sterilization tolerance.

The Vicat softening temperature B50 of 140 °C per ISO 306 does not imply a continuous use temperature in load-bearing applications. Heat aging under device-specific mechanical load is required to establish an acceptable service envelope. Moisture conditioning after extrusion shifts tensile response, increasing elongation and lowering tensile modulus; mechanical testing of finished tubing should be conducted under controlled atmosphere per ISO 291.

Capillary rheometry at 230 °C shows shear-thinning behavior typical of PA12, with apparent viscosity decreasing as shear rate increases from 10 s⁻¹ to 1000 s⁻¹. Exact viscosity-shear-rate master curves are available in the manufacturer’s rheology documentation. This shear-thinning response supports stable flow through annular dies, but excessive shear in narrow die lips can produce melt fracture at high output rates.

Pre-drying is mandatory. The resin should be dried at 80 °C in a desiccant dryer with a dew point of −30 °C or lower to a residual moisture content below 0.10% by weight. Wet pellets can cause hydrolysis in the barrel, producing surface roughness, lumen collapse, and reduced melt strength. Single-screw extruders with L/D ratios from 24:1 to 30:1 and compression ratios of 2.5:1 to 3.5:1 are commonly used for catheter tubing. Barrel set temperatures from feed to metering are typically 200 °C, 210 °C, 220 °C, 230 °C, and 240 °C; adapter and die set points are 225 °C to 230 °C. Melt temperature measured by an immersion probe should remain below 250 °C to limit thermal degradation.

In multi-lumen extrusion, melt-pressure differences across individual lumen mandrels can exceed 5 bar if channel balance is poor. Gear pumps and 100- to 200-mesh screen packs are therefore used to stabilize throughput and filter particles. Cooling is typically conducted in a water bath at 20 °C to 40 °C with vacuum sizing sleeves. Line speed may range from 20 to 80 m/min depending on outer diameter, wall thickness, and cooling length. Quenching below 15 °C at high line speed may induce residual stresses that lead to curvature or downstream stress whitening at sharp bends.

Tooling design uses draw-down ratio (DDR) and draw ratio balance (DRB) to control lumen concentricity. For PA12, die gaps are typically sized so that DDR remains below 3:1 to limit melt draw and molecular orientation. DRB values near 1.0 reduce residual stress asymmetry around the lumen. Initial melt orientation developed during free drawing is partially relaxed in the sizing bath; bowing of the final tube is minimized by centering the mandrel and maintaining uniform quench water temperature.

When Gamma Sterilization Doses Reach 50 kGy, What Changes Appear?

VESTAMID® Care ML19 is used in components that are terminally sterilized by ethylene oxide or gamma irradiation. Gamma compatibility is assessed according to ISO 11137, while ethylene oxide processing follows ISO 11135. At 25 kGy, PA12 typically shows small changes in tensile stress at yield. Published data for this specific formulation at 50 kGy is limited, and device manufacturers therefore validate finished assemblies rather than relying on resin-level values. Gamma-induced chain scission and oxidation are influenced by absorbed moisture and dissolved oxygen; drying the finished device before irradiation can reduce the contribution of radiolytic oxygen species.

Ethylene oxide sterilization generally produces less molecular weight reduction than gamma, but residual ethylene oxide and ethylene chlorohydrin must be measured per ISO 10993-7. Because ML19 has low moisture absorption, condensed moisture during humidification is less than for PA6, but residual gas can still be retained in thin-walled lumens. Aeration time must be established on the worst-case device geometry. Repeated sterilization cycles are not recommended without validation; successive 50 kGy doses may accumulate oxidative degradation products and decrease notched impact strength.

For radiation sterilized finished devices, property retention should be reported as a percentage of pre-sterilization values using tensile bars conditioned per ISO 291. Dimensional change after radiation may be small but measurable in thin walls, particularly if residual orientation is frozen into the tubing. Annealing fiber-free tubing after extrusion can reduce irradiation-induced curl by partially relaxing molded-in stress, but annealing conditions must be selected so that lumen collapse and ovality remain within tolerance.

Biocompatibility Documentation and Regulatory Standards

Biocompatibility documentation for VESTAMID® Care ML19 is organized around ISO 10993-1. The material is supplied with formulation disclosure and change notification appropriate for medical device risk management. The following matrix summarizes common test endpoints and the level of documentation expected for medical tubing applications.

For device designers, the choice between ML19 and alternative tubing materials is usually resolved by comparing required Shore D hardness, moisture uptake, and post-sterilization retention. VESTAMID® Care ML19 occupies a region near 55 Shore D with 400 MPa tensile modulus and 1.2% saturation moisture absorption. PA11 grades may have similar ductility but higher moisture uptake and different low-temperature behavior. PA6 compounds are stiffer and stronger but can exceed 9% saturation moisture absorption, which alters dielectric and mechanical performance. Polyolefin-based medical compounds may require modification to meet the same flexural and kink resistance. Final selection must be made on a device-specific basis using ISO 527-2 tensile bars, ISO 10993 biological evaluation, and ISO 11137 or ISO 11135 sterilization validation.